Provided by Tiger Trade Technology Pte. Ltd.

Assembly Biosciences

31.02
-1.8550-5.64%
Volume:196.27K
Turnover:6.12M
Market Cap:631.48M
PE:-12.08K
High:32.69
Open:32.56
Low:30.50
Close:32.87
52wk High:39.71
52wk Low:20.23
Shares:20.36M
Float Shares:9.17M
Volume Ratio:0.94
T/O Rate:2.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0026
EPS(LYR):-0.5461
ROE:-0.03%
ROA:-2.67%
PB:2.07
PE(LYR):-56.80

Loading ...

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Waters (WAT) and Amgen (AMGN)

TIPRANKS
·
Sep 09

Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead

Dow Jones
·
Sep 09

Assembly Bio Highlights Phase 2 Starts for ABI-6250, GS-1179 in Pipeline Update

Reuters
·
Sep 09

Assembly Biosciences exercises profit share option with Gilead for HSV program

TIPRANKS
·
Sep 09

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for Hsv Helicase-Primase Inhibitor Program

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Gs-1179 Expected to Advance into Phase 2 Trial for Genital Herpes by End of 2026

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program

THOMSON REUTERS
·
Sep 09

Assembly Biosciences Price Target Cut to $45.00/Share from $53.00 by Mizuho

Dow Jones
·
Sep 01

Assembly Biosciences Inc : UBS Initiates Coverage with Buy Rating and Target Price $52

THOMSON REUTERS
·
Sep 01

Assembly Biosciences initiated with a Buy at UBS

TIPRANKS
·
Sep 01

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB)

TIPRANKS
·
Sep 01

U.S. Research Roundup-Autodesk, Hubspot, Oracle

Reuters
·
Sep 01

Assembly Biosciences (ASMB) Receives a Buy from Mizuho Securities

TIPRANKS
·
Aug 31

Assembly Biosciences Price Target Maintained with a $50.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 18

Assembly Biosciences: Strategic Pipeline Expansion, Strong Cash Position Support Unchanged $50 Price Target and Buy Rating

TIPRANKS
·
Aug 18

Assembly Climbs on Quarterly Revenue Beat

Reuters
·
Aug 14

Assembly Bio Releases Corporate Deck Highlighting Clinical-Stage Pipeline, Gilead-Partnered HSV Program

Reuters
·
Aug 14

Assembly Biosciences Q2 Net Loss Narrows as Revenue Rises

Reuters
·
Aug 14

Assembly Biosciences Q2 EPS $(0.20) Beats $(0.65) Estimate, Sales $13.374M Beat $8.599M Estimate

Benzinga Earnings
·
Aug 14